Reply

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 7, 2017, Pages 935-936

  Liu, Vincent X ^a   Fielding Singh, Vikram ^b   Iwashyna, Theodore J ^c,d   Bhattacharya, Jay ^e   Escobar, Gabriel J ^a  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; COST BENEFIT ANALYSIS; EARLY INTERVENTION; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INAPPROPRIATE PRESCRIBING; INFECTION; LETTER; PRESCRIPTION; PRIORITY JOURNAL; VIRUS INFECTION; HOSPITAL MORTALITY; SEPSIS;

ANTI-BACTERIAL AGENTS; HOSPITAL MORTALITY; HUMANS; SEPSIS;

EID: 85030683526     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201704-0774LE     Document Type: Letter

References (6)

1. Pigou AC. The economics of welfare. London: Macmillian and Co.; 1920.
2. Coase R. The problem of societal cost. J Law Econ 1960;3:1–44.
3. Klompas M, Rhee C. The CMS sepsis mandate: right disease, wrong measure. Ann Intern Med 2016;165:517–518.
4. Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, Escobar GJ. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med [online ahead of print] 27 Mar 2017; DOI: 10.1164/rccm.201609-1848OC. Published in final form as Am J Respir Crit Care Med 2017;196:856–863 (this issue).
5. Volchenboum SL, Mayampurath A, Göksu-Gürsoy G, Edelson DP, Howell MD, Churpek MM. Association between in-hospital critical illness events and outcomes in patients on the same ward. JAMA 2016;316:2674–2675.
6. Nathan C, Cars O. Antibiotic resistance: problems, progress, and prospects. N Engl J Med 2014;371:1761–1763.